Exactech (EXAC) Lowered to Sell at BidaskClub

BidaskClub lowered shares of Exactech (NASDAQ:EXAC) from a hold rating to a sell rating in a research report sent to investors on Thursday morning.

A number of other research firms have also issued reports on EXAC. Robert W. Baird lowered Exactech from an outperform rating to a neutral rating and set a $42.00 target price for the company. in a report on Monday, October 23rd. ValuEngine lowered Exactech from a buy rating to a hold rating in a report on Friday, December 1st. Sidoti lowered Exactech from a buy rating to a neutral rating in a report on Monday, October 23rd. Zacks Investment Research upgraded Exactech from a sell rating to a hold rating in a report on Tuesday, December 26th. Finally, Gabelli lowered Exactech from a buy rating to a hold rating in a report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The company has a consensus rating of Hold and a consensus target price of $49.00.

Exactech (NASDAQ:EXAC) remained flat at $$49.25 on Thursday. 256,300 shares of the company’s stock traded hands, compared to its average volume of 182,742. The company has a market cap of $710.38, a PE ratio of 2,462.50, a price-to-earnings-growth ratio of 3.66 and a beta of 0.90. Exactech has a fifty-two week low of $23.75 and a fifty-two week high of $50.95. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.08 and a quick ratio of 2.09.

Several large investors have recently made changes to their positions in EXAC. Schwab Charles Investment Management Inc. raised its holdings in shares of Exactech by 30.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 70,248 shares of the medical equipment provider’s stock worth $2,094,000 after acquiring an additional 16,330 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Exactech by 17.2% during the second quarter. Wells Fargo & Company MN now owns 67,341 shares of the medical equipment provider’s stock worth $2,007,000 after acquiring an additional 9,894 shares in the last quarter. Alliancebernstein L.P. raised its holdings in shares of Exactech by 6.1% during the second quarter. Alliancebernstein L.P. now owns 24,456 shares of the medical equipment provider’s stock worth $729,000 after acquiring an additional 1,400 shares in the last quarter. Teachers Advisors LLC raised its holdings in shares of Exactech by 2.7% during the second quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after acquiring an additional 568 shares in the last quarter. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of Exactech by 11.1% during the second quarter. TIAA CREF Investment Management LLC now owns 34,438 shares of the medical equipment provider’s stock worth $1,026,000 after acquiring an additional 3,444 shares in the last quarter. Institutional investors and hedge funds own 61.22% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2018/02/16/exactech-exac-lowered-to-sell-at-bidaskclub.html.

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply